Lite Strategy, Inc.
LITS Healthcare Biotechnology
Lite Strategy, Inc.’s revenue for fiscal 2024 (year ended June 2024) was $65.3 million, up 33.8% from fiscal 2023. In the quarter to June 2026, EPS fell 11.0% and free cash flow grew 179.3%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow LITS
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Net Income |
+8 more TTM periods Free account |
(11.58) | (39.70) | (60.82) | (71.15) |
Non Cash Items (Other) |
0.74 | 29.91 | 51.83 | 63.06 | |
Accounts Payable Change |
(0.48) | (0.27) | 0.08 | 0.09 | |
Change in payables and accrued liability |
(1.33) | (0.96) | (0.37) | (0.41) | |
Change in other assets and liabilities |
(1.25) | (1.15) | (1.13) | (0.70) | |
Operating Cash Flow |
(13.90) | (12.16) | (10.42) | (9.12) | |
Change in intangibles (net) |
— | — | — | (94.96) | |
Other investing activities |
— | 1.07 | 0.74 | 0.85 | |
Investing cash flow |
(79.55) | (99.43) | (97.33) | (95.11) | |
Equity Repurchase (Common, Net) |
149.51 | 96.98 | 94.82 | 91.92 | |
Financing cash flow |
84.74 | 96.41 | 94.62 | 91.92 | |
Change in Cash |
3.16 | (14.98) | (12.93) | (12.30) | |
Beginning Cash |
18.01 | 18.01 | 18.01 | 18.01 | |
Ending Cash |
21.17 | 3.03 | 5.08 | 5.71 | |
Stock Based Compensation |
0.28 | 0.61 | 0.87 | 1.29 | |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
(3.07) | (2.38) | (1.42) | (1.03) | |
Issuance/Purchase of Shares |
149.51 | 96.98 | 94.82 | 91.92 |